STOCKHOLDERS EQUITY (Details 2) |
12 Months Ended |
---|---|
Dec. 31, 2020
$ / shares
shares
| |
Stockholders Equity Abstract | |
Range of Exercise price | $ / shares | $ 1.19 |
Options outstanding | shares | 500,000 |
Weighted average exercise price | $ / shares | $ 1.19 |
Weighted Average Remaining Life in Years | 1 year 10 months 2 days |
Options exercisable | shares | 500,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|